At the height of polio and H1N1, Canadians were keen to get vaccinated, but vaccine enthusiasm waned once the crisis had passed — what does that mean for COVID-19?
When a crisis like COVID-19 disrupts expectations for the future, it also disrupts how health messaging works. Advertising research shows three ways that health campaigns can succeed in a crisis.
Should people be compelled to take the vaccine? Should you feel guilty for skipping the line? And what about parts of the world where vaccines aren’t readably available? Ethicists have it covered.
Nicholas Steyn, University of Auckland, Waipapa Taumata Rau; Michael Plank, University of Canterbury, and Shaun Hendy, University of Auckland, Waipapa Taumata Rau
New Zealand will have to vaccinate 80-85% to reach population immunity. Until then, a blanket border re-opening, even if only for vaccinated people, would pose a high risk of new outbreaks.
Pressure is mounting to reopen the Canada-U.S. border, but there are risks. How well those risks are managed may be the difference between pandemic recovery or a fourth wave of COVID-19.
While Pfizer is still the preferred vaccine for under 40s, those who don’t want to wait can now talk to their GP about getting an AstraZeneca shot. But what risks and benefits do you need to weigh up?
The federal government has announced COVID-19 vaccination will now become mandatory for aged-care workers. This comes amid a slow and troubled rollout in the sector.
Because COVID-19 is airborne, we can’t know if the shelter system is as safe as it should be without seeing metrics related to ventilation, filtration and occupancy.
National policies must incorporate good practices derived from lessons learnt so far to strengthen their health systems. Critical policy elements include preparedness and response.
Despite having left people more exposed to the delta variant now, the strategy helped protect the most vulnerable during the second wave, so was the right call.
Honorary Enterprise Professor, School of Population and Global Health, and Department of General Practice and Primary Care, The University of Melbourne
Dean Faculty of Health Sciences and Professor of Vaccinology at University of the Witwatersrand; and Director of the SAMRC Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand